Cargando…
Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Autores principales: | He, Shanyang, Wang, Wei, Wan, Zhiyong, Shen, Hongwei, Zhao, Yunhe, You, Zeshan, Liu, Jun, Zhu, Liwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017815/ https://www.ncbi.nlm.nih.gov/pubmed/36922491 http://dx.doi.org/10.1038/s41389-023-00459-1 |
Ejemplares similares
-
Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021) -
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021) -
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
por: Shen, Hongwei, et al.
Publicado: (2021) -
The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway
por: He, Shanyang, et al.
Publicado: (2017) -
Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling
por: He, Shanyang, et al.
Publicado: (2018)